Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Cancers
|
October 14, 2022
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants
Cristina Bottino, Mariella Della Chiesa, Stefania Sorrentino, et al.
Pediatric Blood & Cancer
|
January 29, 2019
Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile
Stefano Parodi, Angela Pistorio, Giovanni Erminio, et al.
Disease Models & Mechanisms
|
July 5, 2020
Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a
Roberta Resaz, Davide Cangelosi, Martina Morini, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 17, 2024
Measurement of 3-O-methyldopa from dried plasma microsamples by high-resolution mass spectrometry: A tool for the diagnosis of patients with high-risk neuroblastoma
Margherita Biondi, Sebastiano Barco, Davide Cangelosi, et al.
Cells
|
November 10, 2023
Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients
Martina Morini, Federica Raggi, Martina Bartolucci, et al.
Cancers
|
April 12, 2022
Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors
Elisa Principi, Elvira Sondo, Giovanna Bianchi, et al.
Frontiers in Oncology
|
June 27, 2022
Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma
Sebastiano Barco, Chiara Lavarello, Davide Cangelosi, et al.
Cancers
|
August 23, 2020
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming
Davide Cangelosi, Martina Morini, Nicolò Zanardi, et al.
Journal of Translational Medicine
|
January 12, 2020
Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with cardiopulmonary bypass
Federica Raggi, Davide Cangelosi, Pamela Becherini, et al.
HLA
|
May 15, 2024
Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing
Ferdinando Bonfiglio, Vito Alessandro Lasorsa, Vincenzo Aievola, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Cancers
|
October 14, 2022
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants
Cristina Bottino, Mariella Della Chiesa, Stefania Sorrentino, et al.
Pediatric Blood & Cancer
|
January 29, 2019
Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile
Stefano Parodi, Angela Pistorio, Giovanni Erminio, et al.
Disease Models & Mechanisms
|
July 5, 2020
Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a
Roberta Resaz, Davide Cangelosi, Martina Morini, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 17, 2024
Measurement of 3-O-methyldopa from dried plasma microsamples by high-resolution mass spectrometry: A tool for the diagnosis of patients with high-risk neuroblastoma
Margherita Biondi, Sebastiano Barco, Davide Cangelosi, et al.
Cells
|
November 10, 2023
Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients
Martina Morini, Federica Raggi, Martina Bartolucci, et al.
Cancers
|
April 12, 2022
Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors
Elisa Principi, Elvira Sondo, Giovanna Bianchi, et al.
Frontiers in Oncology
|
June 27, 2022
Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma
Sebastiano Barco, Chiara Lavarello, Davide Cangelosi, et al.
Cancers
|
August 23, 2020
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming
Davide Cangelosi, Martina Morini, Nicolò Zanardi, et al.
Journal of Translational Medicine
|
January 12, 2020
Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with cardiopulmonary bypass
Federica Raggi, Davide Cangelosi, Pamela Becherini, et al.
HLA
|
May 15, 2024
Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing
Ferdinando Bonfiglio, Vito Alessandro Lasorsa, Vincenzo Aievola, et al.
Page
of 4